Author, date and country | Patient group | Study type (level of evidence) | Outcomes | Key results | Study Weaknesses |
---|---|---|---|---|---|
Lieveld et al 10/2020 Netherlands | 186 symptomatic patients admitted from ED. | Multicenter prospective observational study | Measures of Diagnostic accuracy of LUS | Sensitivity= 91.9% Specificity= 71%. Positive Likelihood Ratio (PLR)=3.2 Negative Likelihood Ratio (NLR)=0.1 Positive Predictive Value (PPV)=73.2% Negative Predictive Value (NPV)=91.0% Area Under Receiver Operator Characteristic Curve (AUROC)=0.81. | Multiplicity when working out the confidence interval width, has not been taken into account. No blinding. |
Sorlini C et al 22/10/2020 Italy | 384 symptomatic ED patients. | Retrospective Cohort Study | Diagnostic accuracy of LUS | Sensitivity=92%, specificity=64.9% NPV=88.6% PPV=73.3% | No protocol for relaying LUS findings. Therefore incomplete reports are not included. |
Volpicelli G et al 20/03/2021 Germany | 1462 symptomatic patients in 20 EDs, ICUs, and COVID units. | International multicenter observational study | The diagnostic accuracy of LUS findings and patient presentations. Patients were divided into 5 groups based on their phenotype. Within these groups high, intermediate, and low probability lung ultrasound patterns were used to create thresholds for positive diagnosis. | In the overall population: High and Intermediate findings had a sensitivity=90.2%, specificity=52.5%. PPV=81.5% NPV=69.8% Accuracy=78.9 HighLUS findings only: sensitivity=60.3%, specificity=88.9%. Accuracy=68.9%. PPV=92.6% NPV=49.1% | High prevalence of COVID-19 |
Haak S et al 18/11/2020 Netherlands | 100 symptomatic ED patients | Prospective cohort study | Primary outcome Diagnostic accuracy of LUS compared to PCR Secondary Outcome Diagnostic accuracy in patients without prior pulmonary or cardiac disease. | Sensitivity=96%, Specificity=59%, NLR=2.36 PLR=0.07 NPV=45% PPV=98% compared to PCR only as reference standard. In patients with no prior cardiopulmonary diseases(n=37): Sensitivity=100% Specificity=76% NPV=100% PPV=67% | High incidence of COVID-19 at time of study. May cause overestimation of diagnostic accuracy. |
Bitar et al 24/05/2021 Kuwait | 92 ICU patients with suspected COVID-19 | observational single-center study | 12 zone LUS used to assess sensitivity. | Sensitivity=96.9 (95%CI 85-99.5) | Diagnostic accuracy of LUS not primary objective. High pre-test probability (77 COVID-19 positive) Only severely ill patients included. |
Narinx N et al 10/09/2020 Belgium | 90 ED patients with suspected COVID-19. | Retrospective study | Diagnostic accuracy of LUS | Sensitivity=93.3% Specificity=21.3% NPV=94.1 PPV=19.2 Accuracy=33.3% | Retrospective design Small incidence rate of COVID-19 in the study |
Brenner D et al 01/03/2021 USA | 174 symptomatic or exposed ED and inpatients | Retrospective Cohort | LUS scans given a quantified score, and measures of diagnostic accuracy taken using ROC curve analysis derived cutoff. | Sensitivity=86% Specificity=71.6% NPV=81.7% PPV=77.7% AUROC=0.84(95%CI 0.78-0.9) When using complete scans, Sensitivity=90.9% Specificity=75.6% NPV=87.2% PPV=82.0% AUROC=0.89(95%CI 0.83-0.96) | High variation in symptom severity and duration, and patient setting may have introduced spectrum bias. One author consults for the equipment manufacturer. However, EchoNous was not involved in the production of this study. |
Schmid et al 07/12/2020 Germany | 135 symptomatic ED patients | Retrospective cohort study | Diagnostic accuracy of LUS | Sensitivity=76.9% Specificity=77.1% PPV=57.7% NPV=89.2% | Funded by multiple external sources. Authors claim no conflict of interest. |
Zanforlin et al 07/12/2020 Italy | 111 ED patients with suspected COVID-19 | Retrospective single center | Diagnostic accuracy of scored LUS results was assessed using ROC curve analysis. | AUROC=0.837 (95%CI 0.75-0.92) using a cutoff score of 3 yielded sensitivity=90% specificity=75% | Composite reference standard of PCR, ABG, and clinical judgement. |
Pare J et al 19/06/2020 USA | 43 symptomatic ED patients | Retrospective cohort study | Sensitivity of LUS vs Chest X ray with PCR reference standard | Sensitivity: LUS=88.9%(95%CI 71.1-97) CXR=51.9%(95%CI 34-69.3) Predictive values calculated as: PPV 77.4% NPV=75.0% | Small sample size, retrospective study, prone to selection bias. The physicians blinded only to RT-PCR results. High prevalence of COVID-19 in testing group. |
Peyroni O et al 21/05/2020 France | 87 ED patients | Prospective observational study | Diagnostic accuracy of symptoms, clinical judgement and Bilateral B lines on LUS. | Diagnostic accuracy of LUS Sensitivity=77% (95%CI 62-88) Specificity=89% (95%CI 75-97 PPV=0.9 (95%CI 0.76-0.97) NPV=0.75 (95%CI 0.60-0.87) PLR=7.09 (95%CI 2.77-18.12) NLR=0.26 (95%CI 0.15-0.45) | High prevalence (57.6%) of COVID-19 in the sample population. LUS was only performed in the most unwell patients. |
Speidel V et al 04/2021 Switzerland | 49 hospital patients with suspected COVID-19. | Prospective cohort study | LUS were quantified using a score out of 36 points. Diagnostic accuracy was measured using ROC curve analysis | AUROC=0.85 The odds ratio was 1.30 per point. With a cutoff of 8/36 points: sensitivity=91%, specificity=76%, PLR=3.84 NLR=0.12. | LUS all carried out by a single physician Values derived from ROC curve analysis from small sample size. |
Redondo et al 27/03/21 Spain | 212 symptomatic ED patients | Observational descriptive study. | Evaluate diagnostic accuracy of LUS when categorised as ‘pathologic’ or ‘non pathologic’ | Sensitivity=82.75 Specificity=71% When detecting interstitial disease. | Confirmation bias potentially introduced as other radiological findings evaluated by the same unblinded clinician. |
Colombi D et al 08/10/2020 Italy | 486 consecutively admitted ED patients. | Retrospective analysis | Diagnostic accuracy of LUS calculated for high and medium prevalence groups. | High prevalence n=247 Sensitivity=94% Specificity=7% PPV=94% NPV=7% AUROC=0.51 Medium prevalence n=239 Sensitivity=93% Specificity=31% PPV=52% NPV=83% AUROC=0.62 | No evaluation of interobserver agreement. Inconsistency in the number of RT-PCR tests carried out on each patient. |
Yassa et al 28/07/2020 Turkey | 296 women admitted to an obstetric unit. | Prospective observational study | Diagnostic accuracy of LUS in screening pregnant women of any gestation. | LUS results: 73.91% sensitive, 94.14% specific. PPV=51.52% NPV=97.72% PLR=12.61 NLR=0.28 Diagnostic accuracy was 92.57%. AUROC=0.799 (Standard error=0.064, 95%CI 0.674-0.923) | Only includes women of child bearing age. No description of any blinding processes. |
Fonsi GB et al 07/09/2020 Italy | 63 symptomatic patients admitted that underwent haematological tests, CT, LUS and RT-PCR. | Prospective observational study | Diagnostic accuracy of LUS, and measure of interobserver agreement. | Sensitivity=68% Specificity=79% PPV=88% NPV=52% AUROC=0.745 (95%CI 0.606-0.884) Interobserver agreement k value = 0.877 | Only used patients who were symptomatic for COVID-19 Inclusion criteria selected more seriously ill patients. |